Fresenius Medical Care AG & Co. KGaA operates within the Kidney dialysis centers sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Fresenius Medical Care AG & Co. KGaA with three other
health care providers in Europe:
Ramsay Generale De Sante SA
of France
(2016
sales of 2.23 billion Euro [US$2.50 billion]
of which 82%
was Hospitals/Surgery),
Fresenius SE & Co KGaA
(29.47 billion Euro [US$33.08 billion]
of which 55%
was Fresenius Medical Care), and
Orpea SA
which is
based in France
(2.84 billion Euro [US$3.19 billion]
).
Sales Analysis.
During the year ended December of 2016, sales at
Fresenius Medical Care AG & Co. KGaA were 16.23 billion Euro (US$18.21 billion).
This
is
an
increase of 6.9%
versus 2015, when the company's sales were 15.18 billion Euro.
This was the fifth consecutive year of sales increases at Fresenius Medical Care AG & Co. KGaA
(and since 2011, sales have increased a total of 77%).
Sales of North America saw an increase
of
9.0% in 2016, from
10.71 billion Euro to 11.67 billion Euro.
Not all segments of Fresenius Medical Care AG & Co. KGaA experienced an increase in sales in 2016:
sales of Corporate / Eliminations fell 48.0% to 13.04 million Euro.
(However, this segment's sales were only a very small portion of the company's overall sales).
Fresenius Medical Care AG & Co. KGaA also experienced decreases in sales in
Latin America (down 7.1% to 645.22 million Euro)
.